PALATIN TECHNOLOGIES, INC. Income Tax Expense (Benefit), Intraperiod Tax Allocation
PALATIN TECHNOLOGIES, INC. (PTN) reported Income Tax Expense (Benefit), Intraperiod Tax Allocation of $1.07 million for the 12-month period ending 2012-06-30, per its 10-K filed 2012-09-10.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitIntraperiodTaxAllocation · last filed 2012-09-10
- PALATIN TECHNOLOGIES, INC. income tax expense (benefit), intraperiod tax allocation for fiscal 2012 was $1.07M, a 67.59% increase from fiscal 2011.
- PALATIN TECHNOLOGIES, INC. income tax expense (benefit), intraperiod tax allocation for fiscal 2011 was $637.39K, a 36.16% decline from fiscal 2010.
- PALATIN TECHNOLOGIES, INC. income tax expense (benefit), intraperiod tax allocation for fiscal 2010 was $998.41K.
| Period end | Income Tax Expense (Benefit), Intraperiod Tax Allocation 12 month |
|---|---|
| 2012-06-30 | $1.07M 10-K · filed 2012-09-10 |
| 2011-06-30 | $637.39K 10-K · filed 2012-09-10 |
| 2010-06-30 | $998.41K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |